Home/Filings/4/0000950170-24-040164
4//SEC Filing

Tucker John H 4

Accession 0000950170-24-040164

CIK 0001604950other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:15 PM ET

Size

5.7 KB

Accession

0000950170-24-040164

Insider Transaction Report

Form 4
Period: 2024-03-29
Tucker John H
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (right to buy)

    2024-03-29+56,02556,025 total
    Exercise: $7.06Exp: 2031-01-25Common Stock (56,025 underlying)
Footnotes (1)
  • [F1]On January 25, 2021, the Reporting Person was granted 112,050 options which were eligible to vest and become exercisable subject to certain performance conditions. On March 29, 2024, the Issuer's Board of Directors determined that the performance conditions for one half (1/2) of the grant were met, resulting in the vesting of 56,025 shares. The remaining 56,025 options were previously forfeited due to failure to meet certain performance conditions.

Documents

1 file

Issuer

scPharmaceuticals Inc.

CIK 0001604950

Entity typeother

Related Parties

1
  • filerCIK 0001303480

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:15 PM ET
Size
5.7 KB